Table: begin end state 1 16 cytoplasmic 17 36 transmembrane 37 47 non-cytoplasmic 48 71 transmembrane 72 82 cytoplasmic 83 105 transmembrane 106 140 non-cytoplasmic 141 162 transmembrane 163 181 cytoplasmic 182 205 transmembrane 206 210 non-cytoplasmic 211 238 transmembrane 239 292 cytoplasmic 293 320 transmembrane 321 325 non-cytoplasmic 326 351 transmembrane 352 356 cytoplasmic 357 378 transmembrane 379 410 non-cytoplasmic
Input: >AO353_20105 MTAAPPTLLQRLKHTSLVTQIVIGLIVGIALALFAPEVAKSTAFIGKVFVSALKAVAPIL VFVLVMASIANHKHGQETHIKPILFLYLLGTFAAAVVAVVASSLFPSSLVLSTHDVAISA PGGISEVLQSLLLSVVDNPISALMNANFIGILAWAIGMGIAIRHAGETTRTVLGDLSNGV TLIVRLVIRFAPLGIFGLVASTLATSGFGALIGYLHLLAVLLGCMLFVALVMNPAIVYWK LRRNPYPLVLTCLRESGITAFFTRSSAANIPVNLELSKRLGLHEDTYSVSIPLGATINMA GAAITITVLTLAAVHTLGIAVDIPTAVLLSVVAAICACGASGVAGGSLLLIPLACSLFGI PSEIAMQVVAVGFIIGVLQDSAETALNSSTDVLFTAAACLGEDEKVQRLA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server